132nd MAINE LEGISLATURE
		LD 582		LR 980(02)
	An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances
	Fiscal Note for Bill as Amended by Committee Amendment " "
	Committee: Health Coverage, Insurance and Financial Services
	Fiscal Note Required: Yes
Fiscal Note
			FY 2025-26	FY 2026-27	Projections  FY 2027-28	Projections  FY 2028-29
Net Cost (Savings)
	General Fund		$0	$90,000	$206,364	$206,364
	Highway Fund		$0	$0	$9,170	$9,170
Appropriations/Allocations
	General Fund		$0	$90,000	$206,364	$206,364
	Highway Fund		$0	$0	$9,170	$9,170
Fiscal Detail and Notes
	This bill requires carriers offering health plans in this State to provide coverage for blood testing for perfluoroalkyl and polyfluoroalkyl substances. The requirements of the bill apply to health plans issued or renewed on or after January 1, 2027. The bill includes General Fund appropriations to the Department of Administrative and Financial Services of $90,000 for the estimated cost to reimburse the insurance carriers, for 6 months of the State's defrayal cost of this new mandate. The mandate will go into effect on all health insurance plans on the marketplace beginning January 1, 2027 and is estimated to cost $180,000 annually, thereafter. The State Employee Health Plan's first impacted plan year will be fiscal year 2027-28 and is estimated to cost $57,313 annually thereafter. The costs are split across the General Fund ($26,364), Highway Fund ($9,170) and all other funds ($21,779).